285
CHAPTER 25
Omnipod 5 Clinical Studies
Contents
25.1. Studies in Children, Adolescents and Adults with
Type 1 Diabetes
................................................. 286
Demographics
...........................................................287
Change in A1C Analysed by Baseline A1C
...............................291
Glycaemic Results by Baseline Treatment
...............................292
Insulin Requirements
.....................................................293
Body Mass Index Results
.................................................293
Omnipod 5 System Use
..................................................294
Adverse Events
...........................................................294
Glycaemic Results at Target Glucose Settings in the Pivotal Study
.....295
25.2. Studies in Very Young Children with Type 1 Diabetes ........... 300
Demographics
...........................................................301
Glycaemic Results
........................................................302
Change in A1C Analysed by Baseline A1C
..............................304
Glycaemic Results by Baseline Treatment
...............................304
Insulin Requirements
....................................................305
Body Mass Index Results
.................................................305
Omnipod 5 System Use
..................................................305
Adverse Events
...........................................................306
Glycaemic Results at Target Glucose Settings
...........................307